Population pharmacokinetics of zolpidem tartrate tablets in healthy volunteers of five different nationalities in China

Chinese Pharmaceutical Journal

Volumn 46, Issue 11, 2011, Pages 850-856

  Shi, Jie ^a,b,c   Guo, Tao ^d   Xia, Dong Ya ^d   Xu, Ning Ning ^a   Deng, Chen Hui ^a   Bi, Shan Shan ^a   Zhou, Tian Yan ^a,b   Lu, Wei ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING INSTITUTE FOR DRUG CONTROL   (China)

^d GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

NONMEM; Population pharmacokinetics; Zolpidem tartrate

Indexed keywords

ZOLPIDEM TARTRATE;

ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; CHINA; CLINICAL PRACTICE; COMPARTMENT MODEL; DEMOGRAPHY; DRUG ABSORPTION; DRUG DOSE ESCALATION; DRUG ELIMINATION; ERROR; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POPULATION RESEARCH; RELIABILITY; SINGLE DRUG DOSE;

EID: 79960077188     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. RING P R, BOSTICK J M. Validation of a method for the determination of zolpidem in human plasma using LC with fluorescence detection[J]. J Pharm Biomed Anal, 2000,22(3):495-504.
2. LAVIANA L, MANGAS C, FERNANDEZ-MARI F, et al. Determination and in-process control of zolpidem synthesis by high performance liquid chromatography [J]. J Pharm Biomed Anal, 2004,36(4):925-928.
3. SONG H J, LI Z, SHI J, et al. High performance liquid chromatographic determination of zolpidem tartrate in human plasma with fluorimetric detection [J]. Chin Pharm J, 2001,36(5):333-335.
4. SONG H J, LI Z, SHI J, et al. Pharmacokinetics and relative bioavailability of zolpidem tartrate tablet[J]. Chin J Clin Pharmacol 2000,16(2):122-124.
5. WEI S L, ZHANG Q. Biopharmaceutics and Pharmacokinetics [M]. 2nd ed. Beijing: Peking University Medical Press, 2004:238-271.
6. RUI J Z, ZHANG Z. The principles and approaches of population pharmacokinetics and population pharmacodynamics [J]. J Med Postgrad, 2005,18(3):246-249.
7. HU M, ZHANG J H, SUN H, et al. Principle of population pharmacokinetics and data analysis by NONMEN method [J]. Pharm Care Res, 2002,2(4):227-230.
8. US. Department of Health and Human Services, Food and Drug Administration. Guidance for industry : Population pharmacokinetics [EB/OL]. FDA, 1999:1-31 http://www.fda.gov/cber/gdins/popharm.htm.
9. ETTE E I. Stability and performance of a population pharmacokinetic model [J]. J Clin Pharmacol, 1997,37(6):486-495.
10. VOZEH S, MAITRE P O, STANSKI D R. Evaluation of population (NONMEM) pharmacokinetic parameter estimates [J]. J Pharmacokinet Biopharm, 1990,18(2):161-173.
11. SHEINER L B, BEAL S L. Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares [J]. J Pharmacokinet Biopharm, 1985,13(2):185-201.
12. SHEINER L B. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data [J]. J Pharmacokinet Biopharm, 1977,5(5):445-479.
13. SHEINER L B. Analysis of pharmacokinetic data using parametric models. III: Hypothesis tests and confidence intervals [J]. J Pharmacokinet Biohparm, 1986,14(5):539-555.